Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125006582 | 12500658 | 2 | F | 20160808 | 20160627 | 20160819 | EXP | KR-PFIZER INC-2016314772 | PFIZER | KIM, E.. CHEMOTHERAPY-INDUCED ENDOMETRIAL PATHOLOGY: MIMICRY OF MALIGNANCY AND VIRAL ENDOMETRITIS.. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH. 2016;8(5):2459-2467 | 63.00 | YR | F | Y | 0.00000 | 20160819 | OT | KR | KR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125006582 | 12500658 | 1 | PS | PACLITAXEL. | PACLITAXEL | 1 | UNK | U | 76131 | ||||||||||
| 125006582 | 12500658 | 2 | SS | CISPLATIN. | CISPLATIN | 1 | UNK | U | 0 | ||||||||||
| 125006582 | 12500658 | 3 | SS | IFOSFAMIDE. | IFOSFAMIDE | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125006582 | 12500658 | 1 | Cervix carcinoma |
| 125006582 | 12500658 | 2 | Cervix carcinoma |
| 125006582 | 12500658 | 3 | Cervix carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125006582 | 12500658 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125006582 | 12500658 | Endometrial disorder | |
| 125006582 | 12500658 | Neutropenia | |
| 125006582 | 12500658 | Septic shock |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |